October 19 proved to be an emotional rollercoaster for Taiwan’s biotechnology investors. Within hours, three major material ...

Siren Biotechnology, a clinical-stage biotechnology company pioneering Universal AAV Immuno-Gene Therapy for cancer, today announced the appointment of Peter Bross, MD, former Chief of the Oncology ...

Laxxon Medical Corp. ("Laxxon Medical" or the "Company"), a pharmaceutical technology company developing advanced drug delivery solutions through its proprietary SPID® (Screen Printed Innovative Drugs ...

Germany is the European Union’s (EU) largest pharmaceutical market by revenue and has the highest medical biotechnology ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical ...

High energy costs are pushing inflation concerns back into focus after crude oil moved above US$100, and that kind of ...

Spread the loveImagine a world where the agonizing wait for a new life-saving drug is drastically cut short, where illnesses ...

Biotech investment is being driven by medical demand, advances in drug development and pharmaceutical demand for new ...

She runs the Medical Research and Education Institute at Moscow State University ...

Inhibikase Therapeutics, Inc. (Nasdaq: IKT), a Wilmington, Delaware-based clinical-stage pharmaceutical company, has appointed Scott M. Wasserman, MD, to its Board... Read More ...

Since 1987, October in the UK has been celebrated as Black History Month, a time to instill pride and reflect on those who ...

Vir Biotechnology appoints David Liu as EVP and CMO, leveraging his immuno-oncology and regulatory expertise for upcoming ...